VIUM
Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs. Vium's digital platform provides physiological biomarkers ... that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies. Vium was founded in 2013 and is headquartered in San Mateo, California, United States.
VIUM
Industry:
Biotechnology Health Care Life Science Medical Device
Founded:
2013-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.vium.com
Total Employee:
51+
Status:
Active
Contact:
(650) 988-8500
Email Addresses:
[email protected]
Total Funding:
53.94 M USD
Technology used in webpage:
Domain Not Resolving Amazon IPv6 ReCAPTCHA Amazon Route 53 Gravity Forms Amazon CloudFront Google Cloud CDN Nginx 1.14 Google Cloud Global Multi-Region
Similar Organizations
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Sharp Edge Labs
Sharp Edge Labs is engaged in the development of biosensors for cellular biology research and high-throughput screening.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lux Capital
Lux Capital investment in Series B - Vium
Founders Fund
Founders Fund investment in Series B - Vium
Future Shape
Future Shape investment in Series B - Vium
Dolby Family Ventures
Dolby Family Ventures investment in Series B - Vium
DCVC
DCVC investment in Series B - Vium
Dolby Family Ventures
Dolby Family Ventures investment in Series A - Vium
AME Cloud Ventures
AME Cloud Ventures investment in Series A - Vium
Founders Fund
Founders Fund investment in Series A - Vium
Lux Capital
Lux Capital investment in Series A - Vium
DCVC
DCVC investment in Series A - Vium
Official Site Inspections
http://www.vium.com Semrush global rank: 13.32 M Semrush visits lastest month: 78
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Vium"
Vium - Org Chart, Teams, Culture & Jobs - The Org
View Vium's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Vium Company Profile 2024: Valuation, Investors, …
The company's biomarkers are derived from artificial intelligence, machine learning and sensor technology and assists in accelerating the pre-clinical …See details»
Vium - Crunchbase Company Profile & Funding
Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC …See details»
Vium's Board of Directors - Team members and org chart - The Org
The board of directors at Vium has a history of experience in the medical and biotech industries, as well as education in fields such as medicine, genetics, molecular biology, biochemistry, …See details»
Vium Company Profile - Office Locations, Competitors ... - Craft
See insights on Vium including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Vium - Company Profile - Tracxn
Nov 21, 2024 · Vium - Provider of living informatics platform for preclinical in vivo drug research. Acquired by Recursion. Raised a total funding of $57.2M over 5 rounds from 6 investors. …See details»
Vium - LinkedIn
Vium | 1,083 followers on LinkedIn. Creating digital biomarkers to transform preclinical research and animal welfare. | Vium is the first company to create a living informatics platform for...See details»
Recursion Acquires Vium Bolstering Its Efforts to Industrialize Drug ...
Jul 28, 2020 · Vium’s platform combines computer vision, machine learning and sensor technologies to non-invasively collect and derive insights from digital biomarkers in preclinical …See details»
Recursion Acquires Vium Bolstering Its Efforts to …
Vium is the first company to create a fully digital end to end Digital Vivarium® platform which is transforming in vivo research. The Vium Digital Vivarium, Vium Cloud, and online Research Suite empower scientists to optimize advances in …See details»
Recursion Pharmaceuticals acquires Vium - 2020-07-28 - Crunchbase
Jul 28, 2020 · Vium Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare.See details»
Vium, Inc - F6S
Vium is the first company to create a living informatics platform for preclinical in vivo drug research. The Vium Digital Vivariumâ„¢, incorporating Vium Smart Housingâ„¢, Vium Cloud …See details»
Recursion Acquires Vium Bolstering Its Efforts to Industrialize Drug ...
Jul 28, 2020 · SALT LAKE CITY-- ( BUSINESS WIRE )-- Recursion, a digital biologyâ„¢ company leading in the industrialization of drug discovery, today announced its acquisition of Vium, a …See details»
Vium | Science Company | Labroots
Jun 26, 2018 · Vium bridges the divide separating Silicon Valley innovation and preclinical drug research, where methodologies, systems, and tools have remained largely unchanged for …See details»
Vium - Company profile | ensun
Vium’s Digital Vivariumâ„¢ and Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning and sensor technology to non …See details»
Vium - VentureRadar
Vium is a translational medicine company focused on improving the success of drug development. ... Find out more about Vium, Bioinformatics.See details»
Recursion Acquires Vium Bolstering Its Efforts to ... - BioSpace
Jul 28, 2020 · Vium’s platform combines computer vision, machine learning and sensor technologies to non-invasively collect and derive insights from digital biomarkers in preclinical …See details»
Vium Improves the Success of Drug Development for …
Founded in 2013, Vium is a translational medicine company focused on improving the success of drug development for pharmaceutical and biotechnology companies, academic researchers, …See details»
Recursion to buy VC-backed Vium - Venture Capital Journal
Jul 29, 2020 · Recursion has agreed to acquire San Mateo, California-based Vium, a digital vivarium company. No financial terms were disclosed. Vium’s backers include Lux Capital, …See details»
Introducing Vium: The Foundation for Living Informatics
Jun 2, 2016 · Vium is introducing the first living informatics approach to transforming preclinical drug research, by applying life sciences, digital technology, and large-scale interpretive …See details»
Vium Expands Digital Vivarium Technology With First On-Premises ...
Jun 21, 2018 · Vium is the first company to create a living informatics platform for preclinical in vivo drug research. The Vium Digital Vivariumâ„¢, Vium Cloud, and online Research Suite …See details»